Biomarker-Guided Trial Led by University Hospital Hamburg-Eppendorf (UKE) Opens New Avenues for Personalized Medicine in COVID-19 saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Issuer: 4TEEN4 Pharmaceuticals GmbH / Key word(s): Study 11.04.2022 / 11:00 The issuer is solely responsible for the content of this announcement. Dipeptidyl Peptidase 3 release is
11.04.2022 Biomarker-guided trial led by University Hospital Hamburg-Eppendorf (UKE) opens new avenues for personalized medicine in COVID-19 | bio-ADM | biomarkers | COVID-19 | DPP3
DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Study results The Biomarkers bio-ADM and DPP3 Complement Post-Cardiac Surgery Diagnostics to Early Detect Organ Failure 24.03.2022
DGAP-News: SphingoTec GmbH / Key word(s): Agreement/Development of Sales SphingoTec and Rivaara Labs Close Exclusive Distribution Agreement for Point of Care Diagnostics in India 17.03.2022 / 10:00 The issuer is solely responsible for the content of this announcement. The collaboration focuses o.